JP2025503594A5 - - Google Patents

Info

Publication number
JP2025503594A5
JP2025503594A5 JP2024540758A JP2024540758A JP2025503594A5 JP 2025503594 A5 JP2025503594 A5 JP 2025503594A5 JP 2024540758 A JP2024540758 A JP 2024540758A JP 2024540758 A JP2024540758 A JP 2024540758A JP 2025503594 A5 JP2025503594 A5 JP 2025503594A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
rna
leukemia
crispr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024540758A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503594A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/060230 external-priority patent/WO2023133505A2/en
Publication of JP2025503594A publication Critical patent/JP2025503594A/ja
Publication of JP2025503594A5 publication Critical patent/JP2025503594A5/ja
Pending legal-status Critical Current

Links

JP2024540758A 2022-01-07 2023-01-06 白血病および骨髄異形成を治療するためのキヌレニン合成および/またはシグナル伝達の阻害 Pending JP2025503594A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263297390P 2022-01-07 2022-01-07
US63/297,390 2022-01-07
PCT/US2023/060230 WO2023133505A2 (en) 2022-01-07 2023-01-06 Inhibition of kynurenine synthesis and/or signaling to treat leukemia and myelodysplasia

Publications (2)

Publication Number Publication Date
JP2025503594A JP2025503594A (ja) 2025-02-04
JP2025503594A5 true JP2025503594A5 (cg-RX-API-DMAC7.html) 2025-12-19

Family

ID=87074305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024540758A Pending JP2025503594A (ja) 2022-01-07 2023-01-06 白血病および骨髄異形成を治療するためのキヌレニン合成および/またはシグナル伝達の阻害

Country Status (5)

Country Link
US (1) US20240350669A1 (cg-RX-API-DMAC7.html)
EP (1) EP4460585A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025503594A (cg-RX-API-DMAC7.html)
CA (1) CA3246102A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023133505A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4762094A1 (en) * 2023-08-15 2026-06-24 The Trustees of Columbia University in the City of New York Antibodies targeting serum amyloid a (saa) and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201414730D0 (en) * 2014-08-19 2014-10-01 Tpp Global Dev Ltd Pharmaceutical compound
US20160361298A1 (en) * 2015-06-11 2016-12-15 Globavir Biosciences, Inc. Methods and compositions for treating cancer
WO2018119440A1 (en) * 2016-12-22 2018-06-28 Calithera Biosciences, Inc. Compositions and methods for inhibiting arginase activity
PH12022550835A1 (en) * 2019-10-18 2023-07-03 Forty Seven Inc Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia

Similar Documents

Publication Publication Date Title
ES2610568T3 (es) Inducción de omisión de exones en células eucarióticas
JP2022078069A (ja) 二本鎖RNAによるα-1アンチトリプシンの特異的阻害のための方法及び組成物
RU2019100094A (ru) МОЛЕКУЛЫ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ УМЕНЬШЕНИЯ УРОВНЯ мРНК PAPD5 ИЛИ PAPD7 ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИОННОГО ГЕПАТИТА В
CN107177598B (zh) 用于抑制BIRC5靶基因mRNA表达的寡核酸分子及其成套组合物
JP2018513668A5 (cg-RX-API-DMAC7.html)
JP2023500661A5 (cg-RX-API-DMAC7.html)
CN102341498A (zh) 通过抑制血管内皮生长因子(vegf)的天然反义转录子治疗vegf相关的疾病
JP2022511550A5 (cg-RX-API-DMAC7.html)
JP2015518714A5 (cg-RX-API-DMAC7.html)
Hu et al. Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs
JP2005517438A5 (cg-RX-API-DMAC7.html)
CN116121246A (zh) 一种新型小激活rna
JP2022500070A (ja) プログラム可能なsiRNA及びその使用
JP2023098926A (ja) Tut4/7発現調節因子を含む癌予防又は治療用薬学的組成物
CN115916978A (zh) 寡核苷酸
JP2020503014A5 (cg-RX-API-DMAC7.html)
CN116515833A (zh) Acvr1c抑制剂在治疗结直肠癌中的应用
JP2023539742A5 (cg-RX-API-DMAC7.html)
JP2019525903A5 (cg-RX-API-DMAC7.html)
JP2019513395A5 (cg-RX-API-DMAC7.html)
US9963705B2 (en) DNMT inhibitors
CN108245527B (zh) 通过miR-1181进行抗癌的方法和药物及其应用
WO2025002247A1 (zh) 靶向人血管生成素样蛋白3的核酸及其用途
JP2022529917A5 (cg-RX-API-DMAC7.html)
JPWO2023013613A5 (cg-RX-API-DMAC7.html)